Pages that link to "Q39508967"
Jump to navigation
Jump to search
The following pages link to Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone (Q39508967):
Displaying 50 items.
- Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications (Q24656111) (← links)
- Clinical applications of mifepristone (Q28278425) (← links)
- Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. (Q30361848) (← links)
- Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review (Q30393860) (← links)
- Update on meningiomas (Q30461960) (← links)
- Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors (Q30581024) (← links)
- Anaplastic meningioma: case report (Q30666617) (← links)
- Diagnosis and treatment of atypical and anaplastic meningiomas: a review (Q31003450) (← links)
- Primary Central Nervous System Tumors in Adults (Q31630591) (← links)
- Progesterone receptor isoforms expression pattern in human chordomas (Q33270934) (← links)
- Review of skull base surgery approaches: with special reference to pediatric patients. (Q33278461) (← links)
- Salvage chemotherapy with CPT-11 for recurrent meningioma (Q33370912) (← links)
- Optic nerve sheath meningiomas. Role of MR imaging. (Q33534807) (← links)
- Antioxidant: a new role for RU-486 and related compounds (Q34157921) (← links)
- Novel chemotherapeutic approaches to brain tumors (Q34480131) (← links)
- Adenovirus-mediated regulable target gene expression in vivo (Q34807993) (← links)
- Proven and potential clinical applications of mifpristone (RU486). (Q34821461) (← links)
- A benefit-risk assessment of medical treatment for uterine leiomyomas (Q34836796) (← links)
- Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas. (Q34885495) (← links)
- Mifepristone. Separating fact from fiction (Q35156210) (← links)
- Progesterone antagonists and progesterone receptor modulators (Q35547299) (← links)
- Specific genes expressed in association with progesterone receptors in meningioma (Q35668372) (← links)
- The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature (Q35683023) (← links)
- A regulatory system for use in gene transfer (Q35686843) (← links)
- Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature (Q35787317) (← links)
- Primary radiotherapy for optic nerve sheath meningioma (Q35980041) (← links)
- Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study (Q36271866) (← links)
- The role of progesterone receptors in meningioma (Q36534701) (← links)
- Emerging drugs in endometriosis (Q36580603) (← links)
- Novel therapies for meningiomas (Q36641500) (← links)
- Meningiomas of the cranial base (Q36714669) (← links)
- Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo (Q36826054) (← links)
- New prospects for management and treatment of inoperable and recurrent skull base meningiomas (Q36877009) (← links)
- Regression of Intracranial Meningioma during Treatment with α1-Adrenoceptor Blocker (Q36892210) (← links)
- Children's Cancer and Leukaemia Group (CCLG): guidelines for the management of intracranial meningioma in children and young people (Q37068833) (← links)
- Orbital meningiomas: surgery, radiotherapy, or hormones? (Q37301186) (← links)
- Management options for cavernous sinus meningiomas (Q37439497) (← links)
- Medical therapies for meningiomas (Q37785808) (← links)
- Treatment recommendations for primary extradural meningiomas (Q37786296) (← links)
- Brain tumors and hormonal factors: review of the epidemiological literature (Q37848121) (← links)
- The unique pharmacological characteristics of mifepristone (RU486): from terminating pregnancy to preventing cancer metastasis. (Q38192568) (← links)
- Genomic and Nongenomic Effects of Mifepristone at the Cardiovascular Level: A Review (Q38966345) (← links)
- Transforming Growth Factor Beta Family in the Pathogenesis of Meningiomas (Q39201329) (← links)
- Study of effectiveness of mifepristone for glioma cell line growth suppression (Q39439445) (← links)
- Progesterone and estradiol effects on SRC-1 and SRC-3 expression in human astrocytoma cell lines (Q39641620) (← links)
- Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential (Q40486441) (← links)
- Management of posterior cranial fossa meningiomas (Q40593779) (← links)
- Surgical resection of cranial base meningiomas. (Q40672504) (← links)
- Mifepristone (RU486): a review (Q40873818) (← links)
- Meningiomas (Q40897030) (← links)